LAKE FOREST, Ill., April 30, 2014 /PRNewswire/ -- Hospira, Inc. /quotes/zigman/346012/delayed/quotes/nls/hsp HSP +2.85% , the world’s leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2014. Net sales for the quarter were $1.1 billion and adjusted* diluted earnings per share were $0.60.
Help employers find you! Check out all the jobs and post your resume.
